ARTICLE | Company News
Trinity files Remune NDA in Thailand
July 30, 2001 7:00 AM UTC
Trinity Medical Group (TMGU) filed an NDA with health authorities in Thailand for its HIV-1 immunogen product, Remune, as a primary treatment for HIV infection. TMGU has a license from Immune Response...